For an expectant couple, discovering they are carrying twins brings an instant wave of profound excitement, closely followed by a rush of logistical and medical questions. High-risk pregnancy protocols are immediately put into motion, and the focus shifts to ensuring absolute precision in early genetic screening.
The thing is, our traditional methods for evaluating prenatal risks have always stumbled when twins enter the equation. Standard maternal serum marker tests, the routine first-trimester blood draws, rely on measuring overall hormone levels in the mother’s blood. Frankly, when there are two fetuses, those chemical signals get completely mixed together, making baseline maternal blood screening notoriously unreliable for multiples. To understand why multiple pregnancies require a much deeper level of diagnostic accuracy, we have to look at how genetic tracking works in the modern era.
This is where the narrative around the non-invasive prenatal test (NIPT test) evolves from a routine screening check into a highly sophisticated piece of bio-informatics. Expectant parents frequently ask a fundamental question: Can this maternal blood check actually identify if they are having twins or multiples in the first place?
This is where things get complicated. Strictly speaking, an NIPT test is not designed to diagnose zygosity or discover a multiple pregnancy from scratch; that remains the structural job of an early ultrasound. What it does, with staggering mathematical precision, is analyze the minute fragments of cell-free fetal DNA (cfDNA) shedding from the placentas into the mother’s bloodstream to screen for conditions like Down syndrome.
This distinct focus on systemic accuracy rather than cheap shortcuts underpins the entire laboratory philosophy of MedGenome. Instead of treating prenatal screening as a broad, one-size-fits-all product panel, they look at the dynamic data variations inherent to multiple gestations.
Decoupling the Genetics of Twins
When evaluating a twin pregnancy, the genetic testing path splits significantly depending on whether the babies are identical or fraternal.
Identical Twins: Shared Blueprints
Because identical twins develop from a single fertilized egg that split early on, they share an identical genetic profile and, usually, a single placenta. For the testing system, this makes analysis highly straightforward. The circulating cfDNA acts essentially like a singleton pregnancy, allowing for an incredibly high detection rate (exceeding 99%) for common trisomies.
Fraternal Twins: The Dual-Fraction Challenge
This is where laboratory engineering faces its true test. Fraternal twins come from two entirely separate eggs fertilized by two different sperm cells, meaning they have completely distinct DNA and separate placentas. They shed different amounts of cfDNA into the mother’s blood. If one placenta sheds 8% DNA and the other sheds only 3%, a low-tier screening could miss a chromosomal issue in the smaller twin entirely. Advanced processing uses sophisticated quality metrics to verify that the “fetal fraction” of both babies crosses the safe testing threshold before delivering a clean report.
Navigating the Biological Crosscurrents
The real-world friction of prenatal genetics often comes down to complex maternal anomalies that a standard textbook simply cannot predict. Consider “Vanishing Twin Syndrome,” a phenomenon where a multiple pregnancy spontaneously transitions into a singleton early in the first trimester.
Even after one embryo stops developing, its placental tissue can continue to shed genetic fragments into the maternal bloodstream for up to eight weeks. If that demised tissue carried a chromosomal abnormality, a standard screen might flag a high-risk warning, creating immense panic for the surviving, perfectly healthy baby.
Balancing Clarity with the Cost of Care
When families begin mapping out their prenatal care roadmap, they inevitably face the economic realities of advanced diagnostics. There is a frequent undercurrent of anxiety regarding the total cost of NIPT testing, which typically ranges between ₹15,000 and ₹30,000 in India depending on how deep the chromosomal panel goes.
It is easy to look at that upfront cost and hesitate, wondering if a basic first-trimester double-marker screen might suffice. However, for a twin pregnancy, the high rate of false positives from traditional blood screens often forces parents into panicked, late-stage amniocentesis—an invasive procedure that carries an inherent, physical risk of miscarriage. By integrating comprehensive genetic counseling directly into their care pipeline, MedGenome ensures that families are never left staring blankly at a complex data printout.
